Business Wire

CA-CEPTON-TECHNOLOGIES

11.1.2021 12:02:50 CET | Business Wire | Press release

Share
World-class Lidar Crowd Analytics Solution Partnership to Transform Smart Spaces With Anonymized Crowd Perception

A ground-breaking lidar-based real-time crowd analytics solution has recently helped Orlando International Airport (MCO) create one of the world’s safest terminals during the COVID-19 pandemic.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210111005374/en/

Deployed by The Indoor Lab, the leading provider for monitoring real-time foot traffic using lidar sensors, the solution - called Safe Place™ - uses Cepton’s award-winning Helius™ Smart Lidar System. Helius enables The Indoor Lab to provide intelligent, anonymized, 3D tracking of people, thereby dramatically improving the usability, safety and cleanliness of large spaces. Further, The Indoor Lab’s ground-breaking visual analytics platform, leveraging the Helius Smart Lidar System, powers the Synect Evenflow Crowd Radar media lights in terminal 2 of the Orlando International Airport.

The project at Orlando International Airport is one of several early projects initiated by The Indoor Lab and Cepton as part of a strategic partnership announced today. The Indoor Lab is Cepton’s early-stage development and analytics partner shaping the future of lidar analytics. This partnership lays the foundation for long-awaited innovations that will save customers time and money, enable more efficient design of public and private commercial spaces, and add a much-needed capability to improve public safety during the COVID-19 pandemic and recovery.

Patrick Blattner, co-founder and Chief Product Officer of The Indoor Lab said: “We have a 15-year history of crowd tracking across retail, events, airports, and stadiums. So, when COVID-19 started spreading exponentially and negatively affected many public and private spaces, we consulted with leaders involved in drafting proposals for the International Franchise Association, including the use of lidar technology to help put the country back on a path towards normalcy. With public concerns focused on cleanliness of public and commercial spaces, we extended our Safe Place platform beyond occupancy and social distancing, creating the first proprietary real-time sanitization detection solution in the market. A Safe Place enabled environment ensures locations have been cleaned, distancing measures are followed, and safer occupancy levels are maintained. Our partnership with Cepton helped us deliver against this promise. Our patent-pending Safe Place platform with real-time cleaning detection is the first of its kind in the world.”

According to The Indoor Lab, the full solution implemented in Orlando led to a drastic improvement in people’s adherence to social distancing through Thanksgiving and into the busy holiday travel season. The unprecedented effectiveness of The Indoor Lab’s innovative crowd analytics solution relies on the unique, high point density and detection range of Cepton’s MMT® -based Vista® -series lidars and Cepton’s award-winning Helius system that provides object dimensions, locations and velocities at high accuracy. The mirrorless, frictionless and rotation-free MMT architecture enables lidars that are reliable and easy to integrate for both indoor and outdoor applications. In addition, Helius allows easy aggregation of data from multiple Cepton lidar sensors to form a comprehensive and extendable network for seamless tracking. For instance, this allows the anonymized tracking of the same person across large overlapping areas, which, according to The Indoor Lab, is another game-changing factor that differentiates Helius from other lidar solutions.

In the Orlando International Airport deployment, the Indoor Lab used seven Vista lidar sensors from Cepton to seamlessly cover nearly 100% of the terminal area of roughly 50,000 square feet, something that would otherwise have required significantly more video cameras, each consuming far more data and storage bandwidth compared to the lidars. Unlike video cameras, lidars also perform accurately 24/7 regardless of lighting conditions.

Another key advantage of lidar, compared to cameras, is that it does not capture biometric data. While lidar sensors provide information to help detect, track and classify objects accurately, they do not show facial features and skin/hair color, maximizing protection of people’s privacy and reducing analytical bias. “The great thing about lidar-based crowd analytics is that it is compliant with privacy laws. At the same time, the system can also integrate with point, tilt, zoom (PTZ) cameras to detect potential public safety risks, such as a bag left behind in a public space or people unexpectedly moving at high rates of speed,” explained Blattner.

The partnership between Cepton and The Indoor Lab extends beyond projects in airports. Using Cepton’s technology, The Indoor Lab is successfully monitoring real-time traffic globally across hotels, stadiums, large commercial venues and retail spaces, such as malls and stores. The Indoor Lab’s software provides state-of-the-art, real-time information on crowd density, as well as dwell times, motion tracking and speed of individuals. Using all of that data, enterprises can optimize their customers’ experience in their spaces – to manage queues, reduce crowding, optimize layout of aisles, walkways and shops, as well as address safety and security risks.

“After evaluating most of the lidar hardware and 3D perception software offerings on the market, The Indoor Lab has identified Cepton to be the leader with a combined solution that provides the point-cloud density, accuracy, reliability, and ease and cost of integration required to properly enable crowd analytics. Together with the Cepton team, we have successfully monitored and analyzed dense crowds in some of the most challenging environments,” said Patrick Mooney, co-founder and CTO at The Indoor Lab.

Dr. Jun Pei, Cepton’s co-founder and CEO, said: “We are grateful for the partnership with The Indoor Lab and for their adoption of Cepton’s cutting-edge technology to deploy their pathbreaking innovations into a range of diverse applications. The power of this partnership is already evident in the remarkable results recently showcased by The Indoor Lab with their other partners.”

“We worked closely with The Indoor Lab to ensure we were able to deliver the capabilities and accuracy needed for their smart space applications at an affordable price. Our Helius team built a ground-breaking solution that combines intelligent, powerful lidar perception with ease of integration and data efficiency. In a future where smart spaces are pivotal to positively transforming people’s experience in travel, retail, hospitality, entertainment and beyond, I’m confident that Helius will continue to set the benchmark for world-class anonymized perception needed by world-leading partners such as The Indoor Lab.”

Cepton will be showcasing its state-of-the-art lidar solutions at CES 2021 from January 11 to January 14, 2021. Please visit Cepton’s virtual booth (requires CES registration) for more information about Helius and Cepton’s full suite of lidar offerings for various markets. During CES, Cepton’s CMO Dr. T. R. Ramachandran will present at an online webinar “Lidar, What’s the Future ” on Tuesday Jan 12 at 2 p.m. (PST), hosted by North American Lighting (NAL). Additionally, Dr. Ramachandran will discuss how lidar is transforming smart cities in a virtual panel discussion “Smart City Roundtable: What is a Smart City ?” on Jan 13 at 2 p.m. (PST), also hosted by NAL. Join the sessions online to learn more about the transformational nature of lidar technology and how Cepton’s smart lidar solutions are uniquely suited for large scale deployments in smart city and smart spaces applications.

About Cepton Technologies, Inc.

Cepton provides state-of-the-art, intelligent, lidar-based solutions for a range of markets such as automotive (ADAS/AV), smart cities , smart spaces and smart industrial applications. Cepton’s patented MMT® -based lidar technology enables reliable, scalable and cost-effective solutions that deliver long range, high resolution 3D perception for smart applications.

Founded in 2016 and led by industry veterans with over two decades of collective experience across a wide range of advanced lidar and imaging technologies, Cepton is focused on the mass market commercialization of high performance, high quality lidar solutions. Cepton is headquartered in San Jose, California, USA, with a presence in Germany, Canada, Japan and India, to serve a fast-growing global customer base. For more information, visit www.cepton.com and follow us on Twitter and LinkedIn .

About The Indoor Lab

The Indoor Lab, is the leading provider for monitoring real-time foot traffic using lidar sensors. The Safe PlaceTM platform is the newest product within their portfolio of foot traffic analytic solutions and is shaping the safe return and re-opening for all businesses in the future. Beyond COVID-19, The Indoor Lab offers the most extensive combined experience in designing, developing, and deploying real-time location services for some of the most heavily trafficked retailers, monuments, airports, and stadiums worldwide. The founders were the first to introduce 3D lidar for public space tracking and have since become the market leaders delivering the most accurate privacy compliant tracking solutions in the world. For more information, visit www.theindoorlab.com and follow us on LinkedIn .

Link:

ClickThru

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

OM Pharma to Unveil the Largest Multi-Country Real-World Evidence Study on Broncho‑Vaxom® (OM‑85) for RTI Prevention at EAACI 202614.6.2026 10:00:00 CEST | Press release

REACH study met its first primary endpoint, showing that Broncho‑Vaxom® (OM‑85) was associated with a 28-38% reduction in respiratory tract infection rates at 12 months and 29-41% reduction at 24 months, comparing post-treatment versus pre-treatment initiation.1 The reduction was observed regardless of the frequency of respiratory tract infections in the previous year (1-3, >3) and across age subgroups (1-5, 6-11, 12-17, 18-64, >64 years).1 By reflecting everyday clinical practice and capturing episodes that necessitated a visit to the doctor, these extensive data offer critical new evidence of the therapy’s long-term relevance for patients suffering from recurrent respiratory tract infections. Evaluating a vast cohort of more than 15,790 paediatric, adolescent, adult and elderly patients in China, Italy, and Belgium, REACH represents the largest and only multi-country real-world evidence study to date for Broncho-Vaxom®.1,2 The study cohort includes patients with different co-morbidit

Incyte Announces New Positive Data at EHA 2026 Showed INCA033989 Achieved Rapid, Robust and Sustained Clinical and Molecular Responses and Was Well Tolerated in Patients with Myelofibrosis and Essential Thrombocythemia13.6.2026 17:15:00 CEST | Press release

In myelofibrosis (MF), INCA033989 delivered rapid and durable clinical benefits including meaningful spleen volume reductions, symptom improvement and anemia responses, both as a monotherapy and in combination with ruxolitinibIn essential thrombocythemia (ET), 87% of patients achieved a hematologic response, including 70% complete responses; responses were rapid (median ~2 weeks to a durable complete hematologic response) and durable (median response duration of 23 weeks)Across MF and ET, INCA033989 consistently reduced mutant CALR (mutCALR) variant allele frequency (VAF) in most evaluable patients, with reductions correlating with clinical responses and supporting its potential for disease modificationFirst-in-class mutCALR-targeted antibody shows potential to modify disease biology in both MF and ETINCA033989 demonstrated a favorable and manageable safety profile with no dose-limiting toxicities, with most patients with MF and ET continuing treatment Incyte (Nasdaq:INCY) today announ

Results from Incyte’s Pivotal Phase 3 frontMIND Trial of Tafasitamab (Monjuvi®/Minjuvi®) Combination Presented at the 2026 European Hematology Association (EHA) Congress Plenary Showed Prolonged Progression Free Survival13.6.2026 12:00:00 CEST | Press release

- frontMIND study evaluating tafasitamab (Monjuvi®/Minjuvi®) in patients with previously untreated high-risk diffuse large B-cell lymphoma (DLBCL) and high-grade B-cell lymphoma (HGBL) selected for the prestigious Plenary Abstracts Session at EHA 2026 - Results showed tafasitamab and lenalidomide plus R-CHOP (Tafa-Len-R-CHOP) significantly prolonged progression-free survival (PFS), reducing risk of disease progression or death by 25% - Positive trends toward PFS benefit with Tafa-Len-R-CHOP were observed acrossprespecified subgroups, including in patients with centrally confirmed lymphoma subtypes and both cell-of-origin (COO) molecular subtypes - The frontMIND data support global regulatory applications for tafasitamab and lenalidomide in addition to R-CHOP for previously untreated DLBCL and HGBL Incyte (Nasdaq:INCY) today announced positive results from the pivotal Phase 3 frontMIND trial evaluating the efficacy and safety of tafasitamab (Monjuvi®/Minjuvi®), a humanized Fc-modified c

Charlotte Tilbury awarded CBE in the King’s Birthday Honours 202612.6.2026 23:31:00 CEST | Press release

Charlotte Tilbury CBE, sole Founder, President, Chairman and Chief Creative Officer of Charlotte Tilbury Beauty, has been awarded a Commander of the Order of the British Empire (CBE) in the King’s Birthday Honours 2026 for services to the beauty and cosmetics industry. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260612679101/en/ Charlotte Tilbury, founder, president, chairman and chief creative officer of Charlotte Tilbury Beauty, who has been awarded a CBE (Commander of the Order of the British Empire) in 2026 for services to the beauty industry and entrepreneurship. (Photo: Charlotte Tilbury team) This honour recognises Charlotte’s contribution to leading and building Britain’s most successful global beauty brand. She has played a defining role in revolutionising the beauty industry and driving economic growth of the UK beauty sector, which has expanded from approximately £17bn in 2013 to over £31bn today. Charlotte Til

IQM Appoints Barbara Venneman, Vanguard Board Director and Former Global Head of Deloitte Digital, to its Board of Directors12.6.2026 18:36:00 CEST | Press release

Venneman brings more than 30 years of digital transformation, AI, and enterprise technology experience as IQM prepares for its planned Nasdaq listing IQM Quantum Computers, the global leader in superconducting quantum computers, today announced the appointment of Barbara Venneman to its Board of Directors. Venneman deepens the Board's expertise in digital transformation, enterprise technology commercialization, and global business scaling as IQM expands its commercial footprint worldwide. Additionally, CEO and Co-founder Jan Goetz will replace Co-founder Juha Vartiainen as the Founder representative on the IQM Board. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260612650938/en/ IQM Appoints Barbara Venneman, Vanguard Board Director and Former Global Head of Deloitte Digital, to its Board of Directors Ms. Venneman joins the IQM Board of Directors following a distinguished career at the intersection of advanced technology, s

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye